Pharma Manufacturing

Pharmaceutical Manufacturing is the sole publication dedicated entirely to the field of drug production and scaling. It aims to share effective strategies that assist professionals in the pharmaceutical industry in: - Enhancing product quality while maintaining compliance with regulations - Minimizing cycle times, inventory levels, and downtime while eliminating waste - Empowering manufacturing and operations teams - Breaking down organizational and informational barriers - Accelerating the time it takes to bring new, manufacturable drugs to market In contrast to broader publications that address the entire pharmaceutical life cycle, Pharmaceutical Manufacturing focuses specifically on the vital areas of manufacturing, quality assurance, and scaling up. The editorial team actively seeks out best practice examples from around the globe, enabling readers to gain insights from their peers and industry experts who are consistently implementing quality by design and scientific manufacturing principles in their operations.

Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#1388430

United States

#789489

Health/Biotechnology and Pharmaceuticals

#671

Traffic sources

Monthly visitors

Articles

PCI Pharma Services touts new sterile fill-finish capabilities in Bedford, New Hampshire

5 days ago | pharmamanufacturing.com | Greg Slabodkin

Large-scale GMP manufacturing activities for sterile fill-finish products are set to begin this summer at PCI Pharma Services’ new 50,000-square-foot facility at its Bedford, New Hampshire campus. The site is the third high-throughput, isolator-based commercial sterile fill-finish facility that the contract development and manufacturing organization has built in the last four years, according to the company.
Editor’s (re)View: It’s time for pharma to make continuous manufacturing a reality

1 week ago | pharmamanufacturing.com | Greg Slabodkin

Continuous manufacturing — the uninterrupted flow of materials and consistent production of finished products — offers a simple proposition. By producing in a continuous flow, manufacturers can potentially meet demand faster and with fewer resources, while reducing costs and boosting supply chain resilience. Although the concept has been around for decades, the pharmaceutical industry has been slow to adopt continuous manufacturing. However, the tide appears to be turning.
Lifecore inks 10-year commercial manufacturing and supply agreement

1 week ago | pharmamanufacturing.com | Greg Slabodkin

Lifecore Biomedical has signed a 10-year commercial manufacturing and supply agreement with an undisclosed, longstanding customer to support the advancement of a novel ophthalmic therapeutic through clinical development and to market.
Flow state: The evolving shape of continuous manufacturing

1 week ago | pharmamanufacturing.com | Greg Slabodkin

As a concept, continuous manufacturing — which relies on a fully integrated process that runs uninterrupted from beginning to end — has been around for many years, providing an alternative to traditional batch manufacturing in which drug production is segmented into a series of slow-moving steps.
Congress hears from stakeholders about domestic pharma manufacturing challenges

1 week ago | pharmamanufacturing.com | Greg Slabodkin

Advanced manufacturing technologies are needed to rebuild America’s domestic production of active pharmaceutical ingredients (APIs) and key starting materials (KSMs), Ronald Piervincenzi, CEO of U.S. Pharmacopeia (USP), testified on June 11 before the House Energy and Commerce Health Subcommittee.
Editor’s (re)View: North Carolina’s booming biotech industry is a model for other states

2 weeks ago | pharmamanufacturing.com | Greg Slabodkin

If you haven’t been to North Carolina recently, you’re missing out on seeing one of the nation’s biggest biotechnology success stories. In the U.S., the two largest life sciences clusters — Boston and the San Francisco Bay Area — often get much of the attention. However, the Tar Heel State has created a biotech hub that rivals those juggernauts.
Cytiva invests $1.6B in global manufacturing capacity with an ‘in-region, for-region’ focus

2 weeks ago | pharmamanufacturing.com | Greg Slabodkin

With an investment of $1.6 billion since 2019, Cytiva announced Wednesday that several capital expenditure projects have been completed — while others are on track — to expand the life sciences company’s capacity and enhance its global supply chain through an “in-region, for-region” manufacturing strategy. Part of Danaher Corporation, Cytiva offers a range of products and services for both biotechnology development and manufacturing.
US sees 185% jump in tenant demand for biomanufacturing space, as lab leasing craters

2 weeks ago | pharmamanufacturing.com | Greg Slabodkin

The U.S. saw a 185% spike in demand for biomanufacturing space over the past six months, as large pharma companies and contract development and manufacturing organizations (CDMOs) looked to expand their domestic operations, according to a new report from commercial real estate and investment management company JLL.
Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed

2 weeks ago | pharmamanufacturing.com | Greg Slabodkin

Just down the road from Charlotte Motor Speedway in Concord, North Carolina, is one of pharmaceutical giant Eli Lilly’s most advanced, state-of-the-art manufacturing facilities. Equipped with high-speed lines, robotics, and automated systems, the Lilly site started commercial production at the end of 2024 after completing construction in only two years — more than twice as fast as the industry average of five years, according to the company.
Fujifilm Biotechnologies’ Holly Springs, North Carolina site is a clone of Danish facility

2 weeks ago | pharmamanufacturing.com | Greg Slabodkin

Building identical large-scale biomanufacturing facilities on two different continents is no small feat. However, that’s the goal of Fujifilm Biotechnologies — formerly Fujifilm Diosynth Biotechnologies — as it looks to begin operations later this year at its new facility in Holly Springs, North Carolina, a booming bedroom community about 20 miles from Raleigh.